Back to search

HDL in atherosclerosis: actor or bystander?

Data up to Jan 2025

Published2003
Citations58
References56

Total Citations Per Year

Abstract

References (56)

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

2001 • 24,089 citations

High density lipoprotein as a protective factor against coronary heart disease

1977 • 5,019 citations

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

1999 • 3,464 citations

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

1989 • 3,169 citations

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

1988 • 2,276 citations

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1999 • 1,708 citations

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1999 • 1,527 citations

Molecular physiology of reverse cholesterol transport.

1995 • 1,452 citations

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

1999 • 1,441 citations

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

1992 • 1,341 citations

THE TROMSØHEART-STUDY

1977 • 1,212 citations

A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction

1991 • 1,184 citations

Cholesterol and mortality. 30 years of follow-up from the Framingham study

1987 • 981 citations

Recent Trends in Acute Coronary Heart Disease — Mortality, Morbidity, Medical Care, and Risk Factors

1996 • 705 citations

Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein

1988 • 643 citations

Cholesterol and Mortality

1987 • 579 citations

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

1987 • 477 citations

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.

1984 • 449 citations

Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk

2000 • 390 citations

The Münster Heart Study (PROCAM). Results of follow-up at 8 years.

1998 • 358 citations

Apolipoprotein A-I containing lipoproteins in coronary artery disease

1987 • 330 citations

HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study

2000 • 319 citations

NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease

1993 • 304 citations

HIGH DENSITY LIPOPROTEIN CHOLESTEROL AND INCIDENCE OF CORONARY HEART DISEASE THE ISRAELI ISCHEMIC HEART DISEASE STUDY

1979 • 271 citations

Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease

1997 • 262 citations

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

1992 • 238 citations

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

2002 • 234 citations

Action of Atorvastatin in Combined Hyperlipidemia

2000 • 231 citations

Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.

1992 • 229 citations

Two-dimensional electrophoresis of plasma lipoproteins: Recognition of new apo A-I-containing subpopulations

1993 • 229 citations

High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects

1982 • 221 citations

Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease

1991 • 207 citations

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

2001 • 194 citations

Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease

2000 • 193 citations

Cholesteryl Ester Transfer Protein Taq I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency

2002 • 154 citations

Physiological role and clinical relevance of high-density lipoprotein subclasses

1994 • 153 citations

Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease

2003 • 138 citations

Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds

2000 • 134 citations

Regulation of the concentration of pre.beta. high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity

1992 • 110 citations

Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients

2002 • 110 citations

High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.

1979 • 99 citations

Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the framingham offspring study

1991 • 98 citations

Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.

1994 • 98 citations

Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease

2001 • 93 citations

Different reactivities of high density lipoprotein2 subfractions with hepatic lipase.

1992 • 92 citations

Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size

2000 • 76 citations

Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics.

1985 • 66 citations

Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.

1987 • 51 citations

Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.

1994 • 38 citations

Normolipidemic Subjects With Low HDL Cholesterol Levels Have Altered HDL Subpopulations

1997 • 36 citations

Rosuvastatin (20, 40 and 80 MG) reduces LDL-C, raises HDL-C and achieves treatment goals more effectively than atorvastatin (20, 40 and 80 MG) in patients with heterozygous familial hypercholesterolaemia

2001 • 20 citations

Rosuvastatin significantly improves lipid parameters and ability to achieve low-density lipoprotein cholesterol goals compared with pravastatin

2003 • 7 citations

Rosuvastatin produces significantly greater reductions in low-density lipoprotein cholesterol and more patients achieve treatment goals compared with simvastatin

2003 • 6 citations

Rosuvastatin is more effective than atorvastatin in modifying lipid profiles and achieving national cholesterol education program adult treatment panel III LDL-cholesterol goals

2002 • 5 citations

Effects of rosuvastatin alone and combined with extended-release niacin on Apo B- and Apo A-containing lipoproteins and triglycerides in atherogenic dyslipidemia

2002 • 2 citations

Cited By (0)

Loading...